Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1315 | 2624 | 41.6 | 84% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANNEXIN | Author keyword | 146 | 49% | 8% | 214 |
2 | ANNEXIN A1 | Author keyword | 113 | 71% | 3% | 90 |
3 | ANNEXIN 1 | Author keyword | 94 | 72% | 3% | 73 |
4 | ANNEXINS | Author keyword | 88 | 64% | 3% | 86 |
5 | LIPOCORTIN 1 | Author keyword | 73 | 71% | 2% | 59 |
6 | ANNEXIN VI | Author keyword | 56 | 84% | 1% | 31 |
7 | ANNEXIN I | Author keyword | 54 | 71% | 2% | 44 |
8 | ANNEXIN A2 | Author keyword | 48 | 51% | 3% | 68 |
9 | ANNEXIN II | Author keyword | 46 | 49% | 3% | 68 |
10 | LIPOCORTIN | Author keyword | 46 | 67% | 2% | 41 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANNEXIN | 146 | 49% | 8% | 214 | Search ANNEXIN | Search ANNEXIN |
2 | ANNEXIN A1 | 113 | 71% | 3% | 90 | Search ANNEXIN+A1 | Search ANNEXIN+A1 |
3 | ANNEXIN 1 | 94 | 72% | 3% | 73 | Search ANNEXIN+1 | Search ANNEXIN+1 |
4 | ANNEXINS | 88 | 64% | 3% | 86 | Search ANNEXINS | Search ANNEXINS |
5 | LIPOCORTIN 1 | 73 | 71% | 2% | 59 | Search LIPOCORTIN+1 | Search LIPOCORTIN+1 |
6 | ANNEXIN VI | 56 | 84% | 1% | 31 | Search ANNEXIN+VI | Search ANNEXIN+VI |
7 | ANNEXIN I | 54 | 71% | 2% | 44 | Search ANNEXIN+I | Search ANNEXIN+I |
8 | ANNEXIN A2 | 48 | 51% | 3% | 68 | Search ANNEXIN+A2 | Search ANNEXIN+A2 |
9 | ANNEXIN II | 46 | 49% | 3% | 68 | Search ANNEXIN+II | Search ANNEXIN+II |
10 | LIPOCORTIN | 46 | 67% | 2% | 41 | Search LIPOCORTIN | Search LIPOCORTIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIPOCORTIN I | 240 | 70% | 8% | 197 |
2 | CALPACTIN I | 199 | 81% | 5% | 121 |
3 | CA 2 DEPENDENT PHOSPHOLIPID BINDING | 173 | 89% | 3% | 79 |
4 | LIPOCORTIN 1 | 147 | 63% | 6% | 149 |
5 | CALPACTIN | 129 | 79% | 3% | 84 |
6 | PHOSPHOLIPID BINDING | 67 | 29% | 8% | 197 |
7 | II TETRAMER | 65 | 78% | 2% | 43 |
8 | LIPOCORTIN | 62 | 65% | 2% | 60 |
9 | FACTOR RECEPTOR KINASE | 62 | 59% | 3% | 70 |
10 | DEPENDENT 35 KILODALTON SUBSTRATE | 58 | 88% | 1% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Annexins: From structure to function | 2002 | 1005 | 320 | 78% |
Annexins: Linking Ca2+ signalling to membrane dynamics | 2005 | 621 | 123 | 77% |
ANNEXINS - THE PROBLEM OF ASSESSING THE BIOLOGICAL ROLE FOR A GENE FAMILY OF MULTIFUNCTIONAL CALCIUM-BINDING AND PHOSPHOLIPID-BINDING PROTEINS | 1994 | 874 | 334 | 78% |
Annexin 1: the new face of an old molecule | 2007 | 184 | 88 | 93% |
The role of annexins in tumour development and progression | 2008 | 108 | 74 | 85% |
Annexin A2 Heterotetramer: Structure and Function | 2013 | 28 | 224 | 68% |
Dynamic reciprocity: the role of annexin A2 in tissue integrity | 2014 | 7 | 76 | 68% |
Annexins and membrane dynamics | 1997 | 244 | 204 | 91% |
The complex understanding of Annexin A1 phosphorylation | 2014 | 5 | 44 | 84% |
Annexin-Phospholipid Interactions. Functional Implications | 2013 | 19 | 167 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NUS IMMUNOL PROGRAM | 13 | 80% | 0.3% | 8 |
2 | UNITE BIOL CELLULAIRE MOL SECRET | 9 | 83% | 0.2% | 5 |
3 | MOL BIOL INFLAMMAT | 8 | 24% | 1.1% | 30 |
4 | U332 INSERM | 6 | 100% | 0.2% | 4 |
5 | U332 | 5 | 29% | 0.6% | 16 |
6 | BIOL BIOCHIM NUTR | 4 | 75% | 0.1% | 3 |
7 | WILLIAM HARVEY BIOCHEM PHARMACOL | 3 | 100% | 0.1% | 3 |
8 | NEUROENDOCRINOL NEUROSCI PSYCHOL MED | 3 | 60% | 0.1% | 3 |
9 | POST MORPHOL | 2 | 67% | 0.1% | 2 |
10 | STATE KEY DISCIPLINE CELL UNIV | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000084739 | TC 99M ANNEXIN V//ANNEXIN V//APOPTOSIS IMAGING |
2 | 0.0000050890 | MATRIX VESICLES//OSSEOUS PLATE//PHOSPHO1 |
3 | 0.0000043420 | CLIC1//CHLORIDE INTRACELLULAR CHANNEL 1//CLIC4 |
4 | 0.0000036403 | S100A4//S100A9//S100A2 |
5 | 0.0000032685 | EXPT THER EUT REPERFUS INJURY//RESOLVINS//LIPOXINS |
6 | 0.0000031087 | MAZUMDAR SHAW TRANSLAT//2 DIMENSIONAL LIQUID CHROMATOGRAPHY//BIOLOGICAL VARIATION ANALYSIS |
7 | 0.0000030906 | LIPID LAYER CRYSTALLIZATION//HELICAL ARRAYS//3D DENSITY MAPS |
8 | 0.0000030531 | FORMYL PEPTIDE RECEPTOR//FORMYL PEPTIDE RECEPTORS//FORMYLPEPTIDES |
9 | 0.0000027837 | SORCIN//TRAP1//HAISHENGSU |
10 | 0.0000027276 | CALUMENIN//BIOCHEM FUNCT PROTE//RETICULOCALBIN |